Trophogen Inc. is a biotechnology company based in Rockville, MD, specializing in protein engineering to improve human and animal health. With their unique platform technology, they develop patented long-acting and highly potent analogs of glycoprotein hormones and growth factors, addressing markets in infertility, elective egg banking, and aggressive cancers.
Their innovative products, such as superagonist analogs of FSH, TSH, and VEGF, along with Nanotechnology, are fully developed and ready for clinical trials. Trophogen's BioSuperior platform technologies are set to surpass current drugs and treatments in the imaging, diagnostic, and therapeutic space, making significant advancements in the field of healthcare.
Generated from the website